Target intelligence / Profile preview

Methyltransferase-like protein 27 (METTL27)

Target
METTL27
Molecular classification
Enzyme, Methyltransferase, Class I S-adenosylmethionine (SAM)-dependent methyltransferase (Rossmann fold)
01

Overview

Methyltransferase-like protein 27 (METTL27, also known as WBSCR27) is a protein encoded by a gene frequently deleted in Williams-Beuren syndrome, a multisystem developmental disorder. Structurally, METTL27 is a Class I SAM-dependent methyltransferase with a canonical Rossmann fold, showing biochemical capacity to bind cofactors such as S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH)[1][2]. Despite extensive structural analyses, its substrate—whether nucleic acid, protein, or small molecule—remains unidentified, and no direct biological partners have been validated. The protein is hypothesized to function as a standalone methyltransferase. METTL27 is not implicated in rRNA methylation, histone modification, or protein methylation based on available experimental results[1]. Its role in disease, especially Williams-Beuren syndrome, is unexplored beyond genomic deletion association, and there is no evidence for its utility as a drug target, biomarker, or safety concern at this time[5].

Other names
METTL27WBSCR27Williams-Beuren syndrome chromosomal region 27 proteinWilliams Beuren syndrome chromosome region 27
02

Mechanism of action

null

03

Biological functions

Unknown (the biological function and substrates have not been conclusively identified)
04

Disease associations

Williams-Beuren Syndrome (gene deletion is associated with the disorder, but METTL27’s direct role is unknown)Williams-Beuren Region Duplication Syndrome

Beyond the preview

Go deeper on Methyltransferase-like protein 27 (METTL27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyltransferase-like protein 27 (METTL27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call